- Home
- ITCI vs LBRDA Comparison
ITCI vs LBRDA Comparison
Compare ITCI & LBRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- LBRDA
- Stock Information
- Founded
- ITCI 2002
- LBRDA 2014
- Country
- ITCI United States
- LBRDA United States
- Employees
- ITCI N/A
- LBRDA N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- LBRDA Cable & Other Pay Television Services
- Sector
- ITCI Health Care
- LBRDA Telecommunications
- Exchange
- ITCI Nasdaq
- LBRDA Nasdaq
- Market Cap
- ITCI 8.0B
- LBRDA 9.5B
- IPO Year
- ITCI N/A
- LBRDA N/A
- Fundamental
- Price
- ITCI $85.60
- LBRDA $86.29
- Analyst Decision
- ITCI Strong Buy
- LBRDA Buy
- Analyst Count
- ITCI 12
- LBRDA 2
- Target Price
- ITCI $97.67
- LBRDA $83.50
- AVG Volume (30 Days)
- ITCI 771.8K
- LBRDA 177.6K
- Earning Date
- ITCI 10-30-2024
- LBRDA 11-07-2024
- Dividend Yield
- ITCI N/A
- LBRDA N/A
- EPS Growth
- ITCI N/A
- LBRDA 20.89
- EPS
- ITCI N/A
- LBRDA 5.43
- Revenue
- ITCI $613,728,000.00
- LBRDA $1,003,000,000.00
- Revenue This Year
- ITCI $48.25
- LBRDA $3.77
- Revenue Next Year
- ITCI $38.47
- LBRDA $2.36
- P/E Ratio
- ITCI N/A
- LBRDA $15.85
- Revenue Growth
- ITCI 46.08
- LBRDA 2.24
- 52 Week Low
- ITCI $58.14
- LBRDA $47.17
- 52 Week High
- ITCI $93.45
- LBRDA $100.44
- Technical
- Relative Strength Index (RSI)
- ITCI 55.65
- LBRDA 50.15
- Support Level
- ITCI $81.83
- LBRDA $85.51
- Resistance Level
- ITCI $86.36
- LBRDA $87.27
- Average True Range (ATR)
- ITCI 2.54
- LBRDA 2.64
- MACD
- ITCI -0.76
- LBRDA -1.47
- Stochastic Oscillator
- ITCI 31.15
- LBRDA 5.30
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.